CG Oncology (CGON) Return on Sales (2023 - 2026)
CG Oncology's (CGON) quarterly Return on Sales came in at 4.09% in Q1 2026, up 1933.0% YoY from 0.2% in Q1 2025, and down 2217.93% on a QoQ basis from 0.18% in Q4 2025.
CG Oncology (CGON) Return on Sales (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of Return on Sales data on file, last reported at 4.09% in Q1 2026.
- Quarterly Return on Sales rose 1933.0% year-over-year to 4.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.71% (up 589.0% YoY) and the FY2025 annual result came in at 0.89%, up 83.0% from the prior year.
- Return on Sales eased to 4.09% in Q1 2026, from 0.18% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.18% in Q4 2025 to a low of 165.51% in Q4 2023.
- A 4-year average of 23.26% and a median of 6.7% in 2025 frame the typical range for Return on Sales.
- The widest YoY moves for Return on Sales: up 16481 bps in 2024, down 2817 bps in 2024.
- Tracing CGON's Return on Sales over 4 years: stood at 165.51% in 2023, then jumped by 100 bps to 0.7% in 2024, then jumped by 75 bps to 0.18% in 2025, then slumped by 2218 bps to 4.09% in 2026.
- The last three Return on Sales figures came in at 4.09% (Q1 2026), 0.18% (Q4 2025), and 1.41% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | -4.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.03% |
| Mar 31, 2026 | -4.09% |
| Dec 31, 2025 | -0.18% |
| Sep 30, 2025 | -1.41% |
| Jun 30, 2025 | -8.70% |
| Mar 31, 2025 | -23.42% |
| Dec 31, 2024 | -0.70% |
| Sep 30, 2024 | -41.30% |
| Jun 30, 2024 | -15.49% |
| Mar 31, 2024 | -4.69% |
| Dec 31, 2023 | -165.51% |
| Sep 30, 2023 | -13.13% |
| Mar 31, 2023 | -0.46% |